(1->4)-beta-D-glucan multiple interactions ISO RGD:736384 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GLRX mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:736384 6480464 1, 2-Dimethylhydrazine results in decreased expression of GLRX mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:736384 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GLRX mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:736384 6480464 Ethinyl Estradiol results in decreased expression of GLRX mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GLRX mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:736384 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLRX mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:736383 6480464 Estradiol results in decreased expression of GLRX mRNA CTD PMID:23019147 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GLRX mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GLRX mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLRX mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLRX mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736383 6480464 Dihydrotestosterone results in increased expression of GLRX mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:736384 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:736384 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736383 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA CTD PMID:12377990 , PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GLRX mRNA CTD PMID:22298810 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736383 6480464 Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA CTD PMID:19684285 , PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736384 6480464 Tetrachlorodibenzodioxin affects the expression of GLRX mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736384 6480464 Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736384 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLRX mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736384 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:736384 6480464 Glucosamine results in increased expression of GLRX mRNA CTD PMID:17178593 2-hydroxypropanoic acid decreases expression ISO RGD:736383 6480464 Lactic Acid results in decreased expression of GLRX mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl affects expression ISO RGD:736383 6480464 3 more ... CTD PMID:20638727 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GLRX mRNA CTD PMID:28522335 3-phenylprop-2-enal increases expression ISO RGD:736383 6480464 cinnamaldehyde results in increased expression of GLRX mRNA CTD PMID:20351055 3-phenylprop-2-enal multiple interactions ISO RGD:736383 6480464 [Cadmium Chloride affects the activity of GLRX protein] inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein] more ... CTD PMID:20351055 3-phenylprop-2-enal increases activity ISO RGD:736383 6480464 cinnamaldehyde results in increased activity of GLRX protein CTD PMID:20351055 4-hydroxyphenyl retinamide increases expression ISO RGD:736384 6480464 Fenretinide results in increased expression of GLRX mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GLRX mRNA CTD PMID:30047161 , PMID:36843608 8-Br-cAMP increases expression ISO RGD:736383 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLRX mRNA CTD PMID:22079614 8-hydroxy-2'-deoxyguanosine affects abundance ISO RGD:736383 6480464 GLRX gene SNP affects the abundance of 8-Hydroxy-2'-Deoxyguanosine CTD PMID:19896490 acetamide increases expression EXP 6480464 acetamide results in increased expression of GLRX mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GLRX mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:736384 6480464 Aflatoxin B1 results in decreased expression of GLRX mRNA CTD PMID:19770486 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of GLRX mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO RGD:736383 6480464 Aflatoxin B1 results in decreased methylation of GLRX gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736383 6480464 Aflatoxin B1 results in decreased expression of GLRX mRNA CTD PMID:22100608 aldehydo-D-glucosamine increases expression ISO RGD:736384 6480464 Glucosamine results in increased expression of GLRX mRNA CTD PMID:17178593 aldehydo-D-glucose multiple interactions ISO RGD:736383 6480464 GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]], GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 all-trans-retinoic acid increases expression ISO RGD:736383 6480464 Tretinoin results in increased expression of GLRX mRNA CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of GLRX mRNA CTD PMID:20488242 amitrole increases expression EXP 6480464 Amitrole results in increased expression of GLRX mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GLRX mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of GLRX mRNA CTD PMID:30779732 antimonite multiple interactions ISO RGD:736383 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA CTD PMID:32076005 antirheumatic drug decreases expression ISO RGD:736383 6480464 Antirheumatic Agents results in decreased expression of GLRX mRNA CTD PMID:24449571 arachidonic acid affects response to substance ISO RGD:736384 6480464 GLRX protein affects the susceptibility to Arachidonic Acid CTD PMID:19373248 aristolochic acid A increases expression ISO RGD:736383 6480464 aristolochic acid I results in increased expression of GLRX mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:736383 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GLRX mRNA CTD PMID:32076005 asbestos affects expression ISO RGD:736383 6480464 Asbestos affects the expression of GLRX mRNA CTD PMID:17297452 azathioprine increases expression ISO RGD:736383 6480464 Azathioprine results in increased expression of GLRX mRNA CTD PMID:22623647 azoxystrobin decreases expression ISO RGD:736383 6480464 azoxystrobin results in decreased expression of GLRX mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:736383 6480464 Benzo(a)pyrene results in increased expression of GLRX mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:736383 6480464 Benzo(a)pyrene results in decreased expression of GLRX mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:736383 6480464 Benzo(a)pyrene results in increased methylation of GLRX promoter CTD PMID:27901495 Benzo[k]fluoranthene decreases expression ISO RGD:736384 6480464 benzo(k)fluoranthene results in decreased expression of GLRX mRNA CTD PMID:26377693 beta-D-glucosamine increases expression ISO RGD:736384 6480464 Glucosamine results in increased expression of GLRX mRNA CTD PMID:17178593 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736383 6480464 Diethylhexyl Phthalate results in increased expression of GLRX mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Dietary Fats] results in increased expression of GLRX mRNA more ... CTD PMID:26496021 , PMID:30580332 bisphenol A affects expression ISO RGD:736383 6480464 bisphenol A affects the expression of GLRX mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GLRX mRNA CTD PMID:25181051 , PMID:32145629 buspirone increases expression EXP 6480464 Buspirone results in increased expression of GLRX mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:736383 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLRX mRNA CTD PMID:29432896 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of GLRX mRNA CTD PMID:17327700 cadmium dichloride multiple interactions ISO RGD:736383 6480464 [Cadmium Chloride affects the activity of GLRX protein] inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein] CTD PMID:20351055 cadmium dichloride decreases expression ISO RGD:736383 6480464 Cadmium Chloride results in decreased expression of GLRX mRNA CTD PMID:26472689 cadmium dichloride increases expression ISO RGD:736383 6480464 Cadmium Chloride results in increased expression of GLRX protein CTD PMID:24527689 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GLRX mRNA CTD PMID:17327700 caffeine decreases expression ISO RGD:736383 6480464 Caffeine results in decreased expression of GLRX mRNA CTD PMID:11793227 carbon nanotube increases expression ISO RGD:736384 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:736383 6480464 CGP 52608 promotes the reaction [RORA protein binds to GLRX gene] CTD PMID:28238834 chloropicrin affects expression ISO RGD:736383 6480464 chloropicrin affects the expression of GLRX mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:736384 6480464 Chlorpyrifos results in decreased expression of GLRX mRNA CTD PMID:37019170 cisplatin increases expression ISO RGD:736384 6480464 Cisplatin results in increased expression of GLRX mRNA CTD PMID:21151649 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of GLRX mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:736383 6480464 [NSC 689534 binds to Copper] which results in increased expression of GLRX mRNA, GLRX protein results in decreased uptake of and results in decreased abundance of and results in decreased susceptibility to Copper CTD PMID:20971185 , PMID:24816595 copper atom increases expression EXP 6480464 Copper results in increased expression of GLRX mRNA CTD PMID:22465980 copper atom affects binding ISO RGD:736383 6480464 Copper binds to GLRX protein CTD PMID:24522867 copper atom multiple interactions ISO RGD:736384 6480464 GLRX protein results in decreased uptake of and results in decreased abundance of and results in decreased susceptibility to Copper CTD PMID:24816595 copper(0) multiple interactions ISO RGD:736383 6480464 [NSC 689534 binds to Copper] which results in increased expression of GLRX mRNA, GLRX protein results in decreased uptake of and results in decreased abundance of and results in decreased susceptibility to Copper CTD PMID:20971185 , PMID:24816595 copper(0) increases expression EXP 6480464 Copper results in increased expression of GLRX mRNA CTD PMID:22465980 copper(0) affects binding ISO RGD:736383 6480464 Copper binds to GLRX protein CTD PMID:24522867 copper(0) multiple interactions ISO RGD:736384 6480464 GLRX protein results in decreased uptake of and results in decreased abundance of and results in decreased susceptibility to Copper CTD PMID:24816595 copper(II) sulfate increases expression ISO RGD:736383 6480464 Copper Sulfate results in increased expression of GLRX mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:736383 6480464 Cyclosporine results in increased expression of GLRX mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:736384 6480464 Cyclosporine results in decreased expression of GLRX mRNA CTD PMID:19770486 cyproconazole increases expression ISO RGD:736384 6480464 cyproconazole results in increased expression of GLRX mRNA CTD PMID:22334560 D-glucose multiple interactions ISO RGD:736383 6480464 GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]], GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 deguelin decreases expression ISO RGD:736383 6480464 deguelin results in decreased expression of GLRX mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:736384 6480464 Dexamethasone results in increased expression of GLRX mRNA CTD PMID:22733784 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GLRX mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO RGD:736384 6480464 Diethylstilbestrol results in increased expression of GLRX mRNA CTD PMID:15171707 , PMID:21041162 diethylstilbestrol decreases expression ISO RGD:736383 6480464 Diethylstilbestrol results in decreased expression of GLRX mRNA CTD PMID:36621641 Diisodecyl phthalate increases expression ISO RGD:736384 6480464 diisodecyl phthalate results in increased expression of GLRX mRNA CTD PMID:25270620 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of GLRX mRNA CTD PMID:17720352 dioxygen multiple interactions ISO RGD:736384 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLRX mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GLRX mRNA CTD PMID:33729688 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:736383 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA CTD PMID:32076005 diquat increases response to substance ISO RGD:736384 6480464 GLRX gene mutant form results in increased susceptibility to Diquat CTD PMID:17893043 diquat increases expression ISO RGD:736384 6480464 Diquat results in increased expression of GLRX mRNA CTD PMID:36851058 diuron increases expression EXP 6480464 Diuron results in increased expression of GLRX mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736383 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:736383 6480464 GLRX protein results in decreased susceptibility to Doxorubicin CTD PMID:16160061 elemental selenium increases expression ISO RGD:736384 6480464 Selenium deficiency results in increased expression of GLRX mRNA, Selenium results in increased expression of GLRX mRNA CTD PMID:16170372 elemental selenium affects expression EXP 6480464 Selenium affects the expression of GLRX mRNA CTD PMID:19351701 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of GLRX mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:736383 6480464 entinostat results in increased expression of GLRX mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:736384 6480464 epoxiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 epoxiconazole decreases expression ISO RGD:736384 6480464 epoxiconazole results in decreased expression of GLRX mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:736383 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLRX mRNA CTD PMID:29432896 ethanol affects expression ISO RGD:736384 6480464 Ethanol affects the expression of GLRX mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:736384 6480464 Ethanol results in increased expression of GLRX mRNA CTD PMID:30319688 fenpyroximate decreases expression ISO RGD:736383 6480464 fenpyroximate results in decreased expression of GLRX mRNA CTD PMID:33512557 fenthion increases expression ISO RGD:736384 6480464 Fenthion results in increased expression of GLRX mRNA CTD PMID:34813904 fluoranthene decreases expression ISO RGD:736384 6480464 fluoranthene results in decreased expression of GLRX mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:736384 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GLRX mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:736384 6480464 Folic Acid results in decreased expression of GLRX mRNA CTD PMID:25629700 folpet increases expression ISO RGD:736384 6480464 folpet results in increased expression of GLRX mRNA CTD PMID:31558096 gemcitabine increases expression ISO RGD:736383 6480464 Gemcitabine results in increased expression of GLRX mRNA CTD PMID:17039268 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of GLRX mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:736383 6480464 GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]], GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 glutathione multiple interactions ISO RGD:736383 6480464 [CDC25B protein co-treated with GLRX protein co-treated with GSR protein co-treated with Glutathione] results in increased reduction of sodium arsenate more ... CTD PMID:20025242 , PMID:24451382 glutathione multiple interactions EXP 6480464 [GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] CTD PMID:12680778 glutathione disulfide affects response to substance ISO RGD:736384 6480464 GLRX protein affects the susceptibility to Glutathione Disulfide CTD PMID:19373248 glycidyl methacrylate decreases expression ISO RGD:736383 6480464 glycidyl methacrylate results in decreased expression of GLRX protein CTD PMID:36641056 hexadecanoic acid multiple interactions ISO RGD:736383 6480464 GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]], GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 hydrogen peroxide increases expression ISO RGD:736383 6480464 Hydrogen Peroxide results in increased expression of GLRX mRNA CTD PMID:12414654 hydroquinone increases expression ISO RGD:736383 6480464 hydroquinone results in increased expression of GLRX mRNA CTD PMID:31256213 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GLRX mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA CTD PMID:22129741 inulin multiple interactions ISO RGD:736384 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GLRX mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:736383 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLRX mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:736383 6480464 Ivermectin results in decreased expression of GLRX protein CTD PMID:32959892 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GLRX mRNA] CTD PMID:23470461 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of GLRX mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:736384 6480464 GLRX protein promotes the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] more ... CTD PMID:20539014 lipopolysaccharide increases activity ISO RGD:736384 6480464 Lipopolysaccharides results in increased activity of GLRX protein CTD PMID:20539014 medroxyprogesterone acetate increases expression ISO RGD:736383 6480464 Medroxyprogesterone Acetate results in increased expression of GLRX mRNA CTD PMID:20843944 menadione increases expression ISO RGD:736383 6480464 Vitamin K 3 results in increased expression of GLRX mRNA CTD PMID:12414654 mercury dichloride affects metabolic processing ISO RGD:736383 6480464 Mercuric Chloride affects the metabolism of GLRX protein CTD PMID:18321861 methimazole increases expression EXP 6480464 Methimazole results in increased expression of GLRX mRNA CTD PMID:30047161 methylene blue multiple interactions ISO RGD:736384 6480464 [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GLRX mRNA CTD PMID:24556215 methylmercury chloride multiple interactions ISO RGD:736383 6480464 methylmercuric chloride results in increased expression of and results in decreased activity of GLRX protein CTD PMID:27180086 monosodium L-glutamate increases expression ISO RGD:736384 6480464 Sodium Glutamate results in increased expression of GLRX mRNA CTD PMID:20111022 monosodium L-glutamate decreases expression ISO RGD:736384 6480464 Sodium Glutamate results in decreased expression of GLRX mRNA CTD PMID:22078008 monosodium L-glutamate multiple interactions ISO RGD:736384 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GLRX mRNA CTD PMID:20111022 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of GLRX mRNA CTD PMID:21515302 N-acetyl-L-cysteine affects response to substance ISO RGD:736383 6480464 GLRX protein affects the susceptibility to Acetylcysteine CTD PMID:17468103 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA CTD PMID:22129741 N-nitrosodimethylamine increases expression ISO RGD:736383 6480464 Dimethylnitrosamine results in increased expression of GLRX mRNA CTD PMID:17547211 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of GLRX mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:736383 6480464 Nickel results in decreased expression of GLRX mRNA CTD PMID:23195993 nickel dichloride increases expression ISO RGD:736383 6480464 nickel chloride results in increased expression of GLRX mRNA CTD PMID:17547211 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of GLRX mRNA CTD PMID:22110744 ochratoxin A decreases expression ISO RGD:736383 6480464 ochratoxin A results in decreased expression of GLRX mRNA CTD PMID:32905824 ozone increases expression EXP 6480464 Ozone results in increased expression of GLRX mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:736384 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GLRX mRNA, [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of GLRX mRNA CTD PMID:25658374 , PMID:34911549 paracetamol decreases expression ISO RGD:736383 6480464 Acetaminophen results in decreased expression of GLRX mRNA CTD PMID:11793227 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GLRX mRNA CTD PMID:33387578 paraquat increases response to substance ISO RGD:736384 6480464 GLRX gene mutant form results in increased susceptibility to Paraquat CTD PMID:17893043 paraquat increases expression ISO RGD:736384 6480464 Paraquat results in increased expression of GLRX mRNA CTD PMID:12732627 parathion increases expression ISO RGD:736384 6480464 Parathion results in increased expression of GLRX mRNA CTD PMID:34813904 PD 0325901 multiple interactions ISO RGD:736383 6480464 [mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of GLRX mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:736383 6480464 mirdametinib results in decreased expression of GLRX mRNA CTD PMID:25119042 pentachlorophenol increases expression ISO RGD:736384 6480464 Pentachlorophenol results in increased expression of GLRX mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736384 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GLRX mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GLRX mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:736383 6480464 perfluorooctanoic acid results in increased expression of GLRX protein CTD PMID:26879310 phenobarbital increases expression ISO RGD:736384 6480464 Phenobarbital results in increased expression of GLRX mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:736384 6480464 Phenobarbital affects the expression of GLRX mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:736383 6480464 Phenylmercuric Acetate results in increased expression of GLRX mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736383 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:736383 6480464 picoxystrobin results in decreased expression of GLRX mRNA CTD PMID:33512557 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GLRX mRNA CTD PMID:17498859 pirinixic acid multiple interactions ISO RGD:736384 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GLRX mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:736384 6480464 pirinixic acid results in increased expression of GLRX mRNA CTD PMID:18301758 more ... potassium chromate decreases expression ISO RGD:736383 6480464 potassium chromate(VI) results in decreased expression of GLRX mRNA CTD PMID:22714537 potassium dichromate multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GLRX mRNA] CTD PMID:23470461 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of GLRX mRNA CTD PMID:23470461 propiconazole increases expression ISO RGD:736384 6480464 propiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 rac-lactic acid decreases expression ISO RGD:736383 6480464 Lactic Acid results in decreased expression of GLRX mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:736383 6480464 Raloxifene Hydrochloride affects the expression of GLRX mRNA CTD PMID:14699072 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GLRX mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:736383 6480464 Rotenone results in decreased expression of GLRX mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:736383 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:736384 6480464 Selenium deficiency results in increased expression of GLRX mRNA, Selenium results in increased expression of GLRX mRNA CTD PMID:16170372 selenium atom affects expression EXP 6480464 Selenium affects the expression of GLRX mRNA CTD PMID:19351701 sodium arsenate multiple interactions ISO RGD:736383 6480464 [CDC25B protein co-treated with GLRX protein co-treated with GSR protein co-treated with Glutathione] results in increased reduction of sodium arsenate, [CDC25C protein co-treated with GLRX protein co-treated with GSR protein co-treated with Glutathione] results in increased reduction of sodium arsenate CTD PMID:20025242 sodium arsenite increases expression ISO RGD:736383 6480464 sodium arsenite results in increased expression of GLRX mRNA CTD PMID:12016162 , PMID:12377979 sodium arsenite affects expression ISO RGD:736383 6480464 sodium arsenite affects the expression of GLRX mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:736383 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GLRX mRNA CTD PMID:32076005 succimer multiple interactions ISO RGD:736384 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GLRX mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLRX mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane increases expression ISO RGD:736383 6480464 sulforaphane results in increased expression of GLRX mRNA CTD PMID:26833863 sunitinib decreases expression ISO RGD:736383 6480464 Sunitinib results in decreased expression of GLRX mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:736383 6480464 tamibarotene results in increased expression of GLRX mRNA CTD PMID:15498508 tebufenpyrad decreases expression ISO RGD:736383 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of GLRX mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:736383 6480464 Temozolomide results in decreased expression of GLRX mRNA CTD PMID:31758290 tert-butyl hydroperoxide multiple interactions EXP 6480464 [GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] CTD PMID:12680778 tert-butyl hydroperoxide increases expression ISO RGD:736383 6480464 tert-Butylhydroperoxide results in increased expression of GLRX mRNA CTD PMID:12414654 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of GLRX mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of GLRX mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLRX mRNA CTD PMID:26496021 , PMID:32741896 tetrahydropalmatine decreases expression ISO RGD:736383 6480464 tetrahydropalmatine results in decreased expression of GLRX protein CTD PMID:20109541 thifluzamide decreases expression ISO RGD:736383 6480464 thifluzamide results in decreased expression of GLRX mRNA CTD PMID:33512557 thioacetamide decreases expression ISO RGD:736383 6480464 Thioacetamide results in decreased expression of GLRX mRNA CTD PMID:11793227 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GLRX mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:736384 6480464 titanium dioxide results in increased expression of GLRX mRNA CTD PMID:27760801 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of GLRX mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736383 6480464 trichostatin A results in increased expression of GLRX mRNA CTD PMID:24935251 more ... triclosan decreases expression ISO RGD:736383 6480464 Triclosan results in decreased expression of GLRX mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:736384 6480464 trimellitic anhydride results in increased expression of GLRX mRNA CTD PMID:19042947 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of GLRX mRNA CTD PMID:21515302 tunicamycin decreases expression ISO RGD:736383 6480464 Tunicamycin results in decreased expression of GLRX mRNA CTD PMID:29453283 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of GLRX mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:736383 6480464 Valproic Acid results in decreased methylation of GLRX gene CTD PMID:29154799 valproic acid affects expression ISO RGD:736383 6480464 Valproic Acid affects the expression of GLRX mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:736383 6480464 Valproic Acid results in increased expression of GLRX mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:736383 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:736383 6480464 vorinostat results in increased expression of GLRX mRNA CTD PMID:22083351 , PMID:27188386
